Epilepsy, Seizures, and MTHFR: The Homocysteine Connection Your Neurologist May Have Missed

Epilepsy affects approximately 50 million people worldwide. For the majority, medication controls seizures effectively. But a significant proportion — up to 30% — have drug-resistant epilepsy, and even among those whose seizures are controlled, the underlying neurology often continues to deteriorate. For a subset of this population, an overlooked biological factor may be contributing to both seizure activity and neurological decline: elevated homocysteine, driven by MTHFR gene variants and B vitamin insufficiency.

This is not a peripheral concern. For people with both epilepsy and MTHFR variants — particularly those on folate-depleting antiepileptic drugs — the interaction between medication and methylation creates a self-reinforcing cycle that can make epilepsy both harder to control and more neurologically damaging over time.

Homocysteine and Seizure Activity

The connection between homocysteine and epilepsy is well-established in the research literature, yet rarely discussed in clinical practice. Homocysteine is a potent excitotoxin — it activates NMDA receptors in the brain, producing neuronal hyperexcitability. This is the same mechanism that underlies seizure generation. In the context of elevated homocysteine, the seizure threshold is effectively lowered — the brain becomes more prone to the abnormal electrical discharges that produce seizures.

Multiple studies have documented elevated homocysteine in people with epilepsy, including both untreated patients and those on antiepileptic medication. The relationship is bidirectional: elevated homocysteine promotes seizure activity, and many antiepileptic drugs directly interfere with folate metabolism, raising homocysteine further.

The Medication-Methylation Crisis

This is the dimension of the homocysteine-epilepsy relationship that most urgently needs clinical attention. The most widely prescribed antiepileptic drugs have significant negative effects on folate and B12 metabolism — the very nutrients needed to clear homocysteine. Valproate depletes carnitine and folate. Carbamazepine and phenytoin induce liver enzymes that accelerate folate degradation. Phenobarbital interferes with folate absorption in the gut. The result, in people already carrying MTHFR variants, can be dramatic homocysteine elevation — creating a neurological environment that is simultaneously more seizure-prone and more neurotoxic.

People with epilepsy on these medications should have homocysteine and folate levels monitored regularly. If elevated, supplementation with methylfolate — not folic acid — and methylcobalamin B12 should be discussed with their neurologist. This is not an alternative to medication. It is an essential adjunctive measure that protects the neurological environment in which antiepileptic drugs are trying to work.

The MTHFR Connection

MTHFR variants are found at elevated rates in epilepsy populations. The mechanism is straightforward: impaired MTHFR function reduces methylfolate available for homocysteine remethylation. Homocysteine accumulates. NMDA receptor hyperactivation follows. The seizure threshold falls. For people carrying both MTHFR variants and antiepileptic medications that deplete folate, the compounding effect can be clinically significant.

Saoirse's Story

NeuroThrive was founded because of a child whose epilepsy was uncontrolled for years — with a homocysteine level of 350 µmol/L driven by severe MTHFR deficiency going undetected. Her neurological decline, her seizures, and her multiple misdiagnoses were all downstream of a methylation failure that no one tested for. The treatment — methylated B vitamins in active forms — produced recovery so dramatic that her medical team described it as extraordinary. She has been seizure-free for five years. Read her full story here.

→ Saoirse's full story — MTHFR, homocysteine 350, and recovery
→ What is MTHFR? Complete guide
→ What is homocysteine and why does it matter?

NeuroThrive™ products are food supplements and are not intended to diagnose, treat, or cure any medical condition. If you or someone you care for has epilepsy, never make changes to antiepileptic medication or supplementation without consulting a neurologist or specialist.